CellSource Co., Ltd. (JP:4880) has released an update.
CellSource Co., Ltd. is set to enhance their adipose-derived stem cell processing service with an advanced extraction technology starting October. The updated process will allow for the removal of senescent cells, improving the quality of cultured stem cells extracted from adipose tissue. The company is committed to continuous service improvement, leveraging knowledge from partnerships and research collaborations.
For further insights into JP:4880 stock, check out TipRanks’ Stock Analysis page.
